Patients with hepatocellular carcinoma (HCC) are at high risk of second primary malignancies. As HCC has become the leading indication of liver transplant (LT), the aim of this study was to investigate whether the presence of HCC before LT could influence the onset of de novo malignancies (DNM).
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation
Gruttadauria, S
;
2021-01-01
Abstract
Patients with hepatocellular carcinoma (HCC) are at high risk of second primary malignancies. As HCC has become the leading indication of liver transplant (LT), the aim of this study was to investigate whether the presence of HCC before LT could influence the onset of de novo malignancies (DNM).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
tri. S. Gruttadauria 2021.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Dimensione
11.57 MB
Formato
Adobe PDF
|
11.57 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
